Strategy

May 14, 2018
Ellen Coleman outlines the highlights of a recent webinar on ensuring that patient advocacy is a key element of a market access strategy.
Apr 07, 2018
Pharmaceutical Executive
The role of the medical affairs professional in the biopharma hierarchy has grown considerably, but challenges remain in its ascent to true strategic partner with the C-suite, writes Lisa Henderson.
Nov 30, 2017
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of "mission command", a military approach to setting direction and executing strategy in the pharmaceutical industry, has developed over the last ten years.
Nov 10, 2017
Before entering into risk-sharing agreements, manufacturers must understand the challenges and implications, writes Kimberly E. White.
Oct 16, 2017
Pharmaceutical Executive
Pamela Buffone from Privacy Analytics discusses growth in the specialty pharma sector and making patient data protection a top priority.
Oct 03, 2017
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Oct 03, 2017
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Sep 20, 2017
Pharmaceutical Executive
Our latest review reveals that those companies scoring well on profit management metrics are best positioned to maintain that crucial edge in performance execution.
Sep 05, 2017
Neil Grubert reviews the UK’s post-Brexit life sciences strategy, with a particular focus on the key area of market access.
Sep 04, 2017
As regulators lower evidentiary requirements for approval to speed development/review of new drugs for unmet medical needs, payers are demanding more data to justify price premiums. How can companies can navigate these complexities?
native1_300x100
lorem ipsum